Italy · Advertising framework
Advertising diagnostic tests and services on websites in Italy
General market orientation, not campaign clearance. Research scope and dates
Product and service rules
Separate diagnostic products from diagnostic services
Legal requirement — paraphrased
IVDR Article 7 prohibits misleading claims for an in vitro diagnostic device. Describe the intended purpose, users and limitations consistently with its conformity documentation. An advertisement for a laboratory consultation also needs the applicable local provider review; the IVDR does not by itself authorise a medical service.
Sources: EU In Vitro Diagnostic Medical Devices Regulation 2017/746
Device advertising has an Italian authorisation layer
Regulator guidance
Applies when: The advertised offer is a device or IVD; software follows this route only if classified accordingly.
Check the national rules for DM and IVD public advertising, the product’s intended user and the applicable ministerial exemptions. Where authorisation is required, approval relates to the message and media. EU conformity alone does not replace this national advertising review.
Sources: Licenze di pubblicità sanitaria; 2025 guidelines for advertising DM, IVD and PMC
Channel rules
Check the complete consumer-facing message
Regulator guidance
The EU consumer-protection framework addresses misleading actions and omissions, including an overall deceptive presentation and undisclosed commercial intent. Review benefits, risks, qualifications and prices as a whole under the national implementing law. Space limits do not provide an automatic exemption from material information requirements.
Sources: EU Unfair Commercial Practices Directive 2005/29/EC
Use the 2025 device internet guidance
Regulator guidance
Applies when: The offer is a DM or IVD subject to the Italian advertising rules.
The 2025 Ministry guidelines distinguish corporate, thematic and product/brand pages. For the specified Facebook product/brand pages, comments and reactions must be disabled and the prescribed disclaimer used; advertising subject to authorisation must follow the Ministry’s approval route.
Review the complete post and the declared destination page, including linked content where the guidelines require it. These Facebook conditions are not a universal rule for every platform, and exempt products need their own classification check.
Sources: 2025 guidelines for advertising DM, IVD and PMC · 2025 DM/IVD/PMC guidance, Facebook product/brand and thematic pages; complete-post review
Review personal data separately from the advertisement
Legal requirement — paraphrased
Identify an Article 6 basis for personal-data processing and an applicable Article 9 condition for health data. Provide appropriate transparency and honour the right to object to direct marketing. Permission to deliver healthcare does not automatically authorise advertising use of patient data; electronic contact and trackers also need their own local review.
Review the whole website journey
Editorial recommendation
Review the product card, metadata, testimonials, booking page and checkout together. Archive the published version and check third-party widgets after updates.
Campaign workflow
Diagnostics & Health Testing: prepare the review
Editorial recommendation
Separate a test kit, laboratory service, screening package and medical interpretation. State the intended population and explain the limits of a positive or negative result. Review both product rules and provider rules when a device is bundled with a clinical service.
Keep a traceable campaign decision
Editorial recommendation
Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.
Pre-publication checklist
- Separate a test kit, laboratory service, screening package and medical interpretation.
- State the intended population and explain the limits of a positive or negative result.
- Review both product rules and provider rules when a device is bundled with a clinical service.
- Record product or provider eligibility before approving claims.
- Archive the final creative and its evidence, permissions and review decisions.
- Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.
Scope and unresolved questions
- The Gazette text of the 2023 healthcare-promotion amendment and the Ministry OTC/SOP application procedure are documented. A final consolidated-law check, regional provider conditions and exact authorised social-media functions remain necessary. AGCOM disclosure and registration thresholds do not replace healthcare advertising authorisation.
- This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates
Advertising diagnostic tests and services on websites in Italy requires a distinction between the test product, the laboratory service and the interpretation of the result. Use this framework to review those layers and the limits of the advertised outcome.
On a website, the headline, product card, testimonial, embedded video and booking or checkout page all contribute to the message. Follow the rules below across that journey, rather than reviewing the landing-page text in isolation.
General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.
How to use this national baseline
Editorial overview
This framework combines researched national rules with editorial review steps. Italian medicine, device and medical-information baseline plus EU requirements. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.
The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.
Sources
- EU In Vitro Diagnostic Medical Devices Regulation 2017/746
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- Licenze di pubblicità sanitaria
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- 2025 guidelines for advertising DM, IVD and PMC
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- EU Unfair Commercial Practices Directive 2005/29/EC
EU framework implemented through national law; sector rules and local implementation also apply.
- EU General Data Protection Regulation 2016/679
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
From framework to action
Local expertise in Italy
Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in Italy.
Medical & health marketing
No partners listed in this category yet.
Marketing & sales advisory
No partners listed in this category yet.
Business & project coordination
No partners listed in this category yet.
Join the local partner directory
Would you like your company to be listed?
Talk to us about the terms of a listing. Leave your details and we will get in touch.